ImmunoPrecise Antibodies Aktie - IPA

ImmunoPrecise Antibodies Ltd (IPA) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

6,50

( - )

Gebot

6,31

Fragen

6,75

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

322,831M

Handelsende

6,50

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

$ 342.188

Ausgegebene Aktien

49.666.372

Dividendenrendite (LTM)

Kurs-Gewinn-Verhältnis

-9,16

Gewinn pro Aktie (EPS)

-0,27

Erlöse (LTM)

28,08M

Nettogewinn (LTM)

-12,25M

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partner... MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas. Mehr anzeigen

Sektor

Branche

Website

www.mindwalkai.com

Hauptsitz

Austin, United States

Gegründet

1983

ImmunoPrecise Antibodies Ltd is listed in the sector of the TSX Venture Börse with ticker IPA. The last closing price for ImmunoPrecise Antibodies was $6,50. Over the last year, ImmunoPrecise Antibodies shares have traded in a share price range of $ 0,00 to $ 0,00.

ImmunoPrecise Antibodies currently has 49.666.372 shares in issue. The market capitalisation of ImmunoPrecise Antibodies is $322,83 million. ImmunoPrecise Antibodies has a price to earnings ratio (PE ratio) of -9.16.

IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant

IPA's Subsidiary BioStrand Secures Second VLAIO Research GrantIPA subsidiary BioStrand receives grant to expand LENSai platform by linking...

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial Intelligence-Driven Analytics...

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with...

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from...

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03 In vivo, IND enabling evaluations of PolyTope®...

ImmunoPrecise lance le programme d'anticorps candidat TATX-112 pour le traitement du cancer et de la maladie d'Alzheimer

Traitement potentiel de la maladie de Parkinson et d'autres affections neurodégénératives IMMUNOPRECISE ANTIBODIES LTD. (la "Société" ou "IPA...

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's...

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

Potential to Treat Parkinson’s and Other Neurodegenerative Diseases IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX...

ImmunoPrecise identifie un anticorps unique, le 23-H7, qui démontre une efficacité in vivo, un mécanisme d'action alternat...

L'anticorps bloque l'interaction de liaison DFR/ACE2 par le biais d'un mécanisme d'action alternatif L'anticorps se lie à tous les variants...

ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action & B...

Blocks the RBD/ACE2 binding interaction indirectly through an alternative mechanism of action Binds to all tested variants of concern, likely...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

IPA - Frequently Asked Questions (FAQ)

What is the current ImmunoPrecise Antibodies Ltd share price?

The current share price of ImmunoPrecise Antibodies Ltd is $ 6,50

How many ImmunoPrecise Antibodies Ltd shares are in issue?

ImmunoPrecise Antibodies Ltd has 49.666.372 shares in issue

What is the market cap of ImmunoPrecise Antibodies Ltd?

The market capitalisation of ImmunoPrecise Antibodies Ltd is CAD 322,83M

What is the 1 year trading range for ImmunoPrecise Antibodies Ltd share price?

ImmunoPrecise Antibodies Ltd has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of ImmunoPrecise Antibodies Ltd?

The price to earnings ratio of ImmunoPrecise Antibodies Ltd is -9,16

What is the cash to sales ratio of ImmunoPrecise Antibodies Ltd?

The cash to sales ratio of ImmunoPrecise Antibodies Ltd is 4,14

What is the registered address of ImmunoPrecise Antibodies Ltd?

The registered address for ImmunoPrecise Antibodies Ltd is Industrious 823 Congress Ave, Austin, Texas, 78701

What is the ImmunoPrecise Antibodies Ltd website address?

The website address for ImmunoPrecise Antibodies Ltd is www.mindwalkai.com

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

ImmunoPrecise Antibodies Ltd (IPA)

ImmunoPrecise Antibodies Ltd (IPA) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über ImmunoPrecise Antibodies Ltd

IPA Neueste Nachrichten

IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03

ImmunoPrecise lance le programme d'anticorps candidat TATX-112 pour le traitement du cancer et de la maladie d'Alzheimer

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

ImmunoPrecise identifie un anticorps unique, le 23-H7, qui démontre une efficacité in vivo, un mécanisme d'action alternat...

ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action & B...

IPA - Frequently Asked Questions (FAQ)

IPA Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

ImmunoPrecise Antibodies Ltd (IPA)

ImmunoPrecise Antibodies Ltd (IPA) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über ImmunoPrecise Antibodies Ltd

IPA Neueste Nachrichten

IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03

ImmunoPrecise lance le programme d'anticorps candidat TATX-112 pour le traitement du cancer et de la maladie d'Alzheimer

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

ImmunoPrecise identifie un anticorps unique, le 23-H7, qui démontre une efficacité in vivo, un mécanisme d'action alternat...

ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action & B...

IPA - Frequently Asked Questions (FAQ)

IPA Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Warum ADVFN beitreten?

Alles, was seriöse Trader brauchen.

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS